Hancock Whitney Corp Repligen Corp Transaction History

Hancock Whitney Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $1.72 Million - $2.76 Million	-10,682 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$247.59 - $304.47 $17,578 - $21,617	71 Added 0.67%	10,682 $2.83 Million
Q3 2021 Nov 04, 2021	SELL	$194.77 - $324.21 $1.73 Million - $2.88 Million	-8,898 Reduced 45.61%	10,611 $3.07 Million
Q2 2021 Aug 09, 2021	SELL	$165.87 - $220.95 $334,393 - $445,435	-2,016 Reduced 9.37%	19,509 $3.89 Million
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $254,862 - $319,705	-1,413 Reduced 6.16%	21,525 $4.19 Million
Q4 2020 Feb 09, 2021	SELL	$148.08 - $206.57 $70,782 - $98,740	-478 Reduced 2.04%	22,938 $4.4 Million
Q3 2020 Nov 05, 2020	SELL	$122.51 - $158.27 $48,146 - $62,200	-393 Reduced 1.65%	23,416 $3.46 Million
Q2 2020 Jul 30, 2020	SELL	$94.33 - $140.48 $197,527 - $294,165	-2,094 Reduced 8.08%	23,809 $2.94 Million
Q1 2020 May 08, 2020	BUY	$84.96 - $109.14 $87,678 - $112,632	1,032 Added 4.15%	25,903 $2.5 Million
Q4 2019 Feb 06, 2020	BUY	$73.84 - $93.08 $1.84 Million - $2.31 Million	24,871 New	24,871 $2.3 Million

476

54.5M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.87B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.